Monday, October 5, 2026
26.4 C
Bengaluru

What will Pharma of the Future Look Like?

In a recent MedicinMan Poll on LinkedIn, it was clear that pharma field forces have hit a brick wall. Other than GPs, very few specialist doctors seem interested in meeting Medical Reps.

This is in keeping with the trends in the US and European markets, where Medical Reps meet with doctors only three or four times a year. If this is the case in markets where innovative molecules are available, it is not surprising that doctors in India are not keen on meeting with Medical Reps once a month, let alone twice a month just to be reminded of branded generic names. As if doctors have some memory problems!

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

spot_img

Related Articles

spot_imgspot_img